Rosenberg equities

Rosenberg Global Equities Perspectives

  • Economy and markets: Trade deal optimism provides boost
  • Factors: Shift to ‘risk on’ hurts Low Volatility but lifts Value
  • Valuation: It’s always darkest before the dawn
  • Earnings: Room for improvement
  • Outlook: Fragile up-tick in 2020

Economy and markets

Global equities had a strong final quarter of the year, with the MSCI World Index advancing 8.3% in dollar terms. The announcement of a ‘Phase One’ trade deal between the US and China and a reduction in uncertainty regarding Brexit helped lift markets worldwide. US stocks were bolstered by strong domestic economic data, encouraging corporate results, dovish monetary policy by the Federal Reserve (the Fed) and the easing of trade tensions; the three major US indices registered all-time highs during the period. European shares also gained, with UK stocks buoyed by trade optimism and the Conservative Party victory in December’s general election.

Sector-wise, traditional defensives (with the exception of healthcare) underperformed the broader market in a risk-on environment. Pro-cyclical sectors outperformed, with technology stocks generally leading the charge across most major regions. See Appendix for more details.


Our factor monitor, Exhibit 1 below, plots factor returns in Q3 and Q4 2019. The monitor is grouped by the four factor families – Low Volatility, Quality, Momentum and Valuation – and shows both simple common factors as well as Rosenberg Equities’ proprietary factors.

Exhibit 1: Rosenberg Equities Factor MonitorSource: Rosenberg Equities. Factor returns to 31 December 2019. The charts show univariate factor returns based on the MSCI World Index universe and are square root of market cap weighted and net of market returns. Factors shown are simple risk factors and Rosenberg Equities’ proprietary factors - see Important Information section for additional information on Rosenberg proprietary measures. Rosenberg proprietary factors are not individually available as investment strategies and the factor returns shown should not be used to extrapolate the performance of Rosenberg Equities’ strategies. Past performance is not a guide to future performance.

During September, investor risk appetite increased as trade tensions eased and economic data surprised on the upside. This led to a sharp reversal in factor performance away from Low Volatility and Quality towards Value. While the intensity of the initial snap-back subsided, these factor trends continued into and throughout Q4 2019.

The worst-performing factor in Q4 was Low Volatility which, according to our data, experienced its weakest calendar quarter since Q4 2016. Momentum also underperformed given its current alignment with Low Volatility. Perhaps surprisingly given the ‘risk on’ nature of the market, Quality only modestly underperformed in Q4; taking a closer look, we can see that this was due to the strong performance of higher-beta technology stocks that also exhibited quality characteristics. Driven by a more pro-cyclical market, Value was the best-performing factor in Q4, with positive performance across both book value and earnings dimensions, as well as Rosenberg Equities’ proprietary valuation measure.


In our recent paper, “Value investing in a growth stock bull market: it’s always darkest before the dawn”[1], we showed how the recent strong gains in already richly-priced stocks had driven equity market mispricing to its highest level in 20 years. Such elevated mispricings have, in the past, preceded significant changes, such as those following the Nifty Fifty bubble in the early 1970s and the Dotcom bubble of the late 1990s.

The chart below echoes this view, plotting the rolling 10-year annualised outperformance of the 20% of US stocks with the lowest price-to-earnings ratios over the 20% with the highest ratios. The consistent outperformance of lowly valued companies is clear – the stocks with the lowest P/E ratios have delivered higher returns (blue marks in the chart) in 94% of monthly rolling 10-year periods since 1961. The recent ascendancy of the most expensively valued stocks, then, is highly unusual – the 2010s were only the second decade, after the 1990s, in which they outperformed.

While such anomalous conditions are clearly challenging for valuation-oriented investors, the chart also offers some comfort. In the past, periods of outperformance by high P/E stocks have been followed by sharp, and enduring, reversals in which lowly-valued stocks have regained market leadership. We expect the same to occur as the recent growth stock bull market comes to a conclusion, setting up a much more favourable environment for value investors in the decade to come.



Exhibit 2: Rolling 10-year annualised outperformance of low vs. high P/E stocks in the US market, 1961–2019

Source: WisdomTree 2020 Outlook; Kenneth French Data Library, returns to the highest and lowest 20% of stocks by P/E, 7/31/1951–11/30/2019; Rosenberg Equities.


Global equity markets may be touching multi-year highs, but revisions into earnings season are still muted – we believe this is a positive signal for future returns. The recent trend has been good, particularly when looking at earnings magnitude – but there is still room for improvement, especially on earnings breadth measures. The chart below plots the analyst revision ratio (up vs. down) alongside the returns of the MSCI World Index. This shows that earnings revisions have been on the low side following the concerns over trade and Brexit impact on global equities. However, with the first stage of a US-China trade agreement signed, reduced Brexit uncertainty since the UK election and the Fed unlikely to raise interest rates any time soon, the cause for pessimism is evaporating. Historically, as earnings momentum picks up, markets have rallied.

Exhibit 3: Earnings forecast revision ratios and index returns, MSCI World, 2009-2019

Source: IBES, MSCI. Index returns in USD. Data from 31/01/09 to 31/12/2019. Earnings revision ratio is calculated by taking the difference between the number of analyst upgrades and analyst downgrades, divided by the total number of analyst revisions on a monthly basis. An earnings revision ratio above zero means that there were more upgrade revisions than downgrade revisions.


Global economic growth has been resilient as stimulus has found traction. The interim trade deal between the US and China should help drive external growth and further bolster industrial activity in the near term. Looking ahead we expect:

  • Any trade-related rebound to be muted as political uncertainty weighs on business investment and US domestic demand. In the Eurozone, manufacturing weakness risks spilling over to other areas of the economy.
  • We expect the Fed to hold rates for most of 2020, but remain poised to ease on any signs of weakness towards year-end. The ECB’s room for manoeuvre is limited.
  • Global equities expected to deliver 10% earnings growth in 2020, well spread across most major sectors.
  • Despite re-rating in 2019, equity valuations look attractive relative to government bonds and only neutral in absolute terms. Market-wide valuations also mask a significant divergence between stock valuations, offering opportunities for stock pickers.


Global sector returns (MSCI World Index), all periods as at 31 December 2019Source: Rosenberg Equities, MSCI. Exhibit shows cumulative return of each sector in USD over the period shown to 31/12/19. Sector returns are based on GICS classifications, calculated with gross dividends re-invested in USD terms.

Regional sector returns, Q4 2019Source: Rosenberg Equities, Thomson Reuters DataStream, I/B/E/S, S&P, MSCI as of 31/12/19. Past performance is not a guide to future performance. It is not possible to invest in an index. Index returns calculated with gross dividends re-invested in local currency terms. Sectors based on GICS classifications.

Important Information

Additional information on Rosenberg proprietary factor measures: ‘Rosenberg Quality’ combines proprietary measures of Earnings Sustainability and forecasted change in Earnings Sustainability; ‘Rosenberg Value’ combines proprietary valuation and earnings forecast models as well as a machine learning ‘value trap’ model; ‘Rosenberg Momentum’ combines price momentum with analyst revisions and a natural language processing news sentiment measure.


This communication is for professional or institutional investors only and must not be relied upon by retail clients or investors. Circulation must be restricted accordingly. Any reproduction of this information, in whole or in part, is prohibited.


This material is published for informational purposes only and is neither an offer to enter into, or a term or condition of any business or agreement with the recipient or any other party, nor is it a solicitation for any services, securities, or funds herein, nor is it intended to provide investment, tax, or legal advice. If this material refers to funds, investments made therein are subject to the relevant fund documents. This material is not intended for distribution to persons or in jurisdictions where prohibited. No representation is made that any of the services, securities, or funds herein are suitable for any particular investor, and therefore, any prospective investor should consult their financial or other advisors about the appropriateness thereof. No representation or warranty is given as to the accuracy or completeness of this material. Investments may decrease in value and that past or backtested performance is no guide to future performance. Forward-looking or simulated data or information herein are subject to inherent limitations and are based upon assumptions that may not materialize, and may vary significantly from actual results. Investment models, research, and risk controls described herein do not guarantee against loss of principal or that any investment objectives shown herein will be achieved. The data, projections, forecasts, anticipations, hypotheses and/or opinions herein are subjective, and are not necessarily used or followed by the firm or its affiliates who may act based on their own opinions and as independent departments or entities within the organization. This information is always subject to change and all rights are reserved thereof. Performance shown, unless otherwise stated, is gross of management fees. An investor’s actual return will be reduced by management fees and other expenses the investor may incur.

The firm seeks to achieve its clients’ investment objectives primarily through reliance on the modelling of proprietary and 3rd party financial and non-financial data, information, and considerations, the sources, weights, and implementation of which may be subject to change and/or the discretion of the firm regardless of whether described herein or elsewhere. Although many of its investment approaches are driven by bottom-up stock selection akin to that of a traditional fundamental investor, the firm seeks to achieve its clients’ investment objectives primarily in reliance on analytical models. The goal of the firm’s systematic approach is not to replicate a perfect “model” portfolio; instead, like other long-term, fundamentally oriented investors, it seeks to create portfolios possessing ex ante those fundamental and statistically important characteristics reflecting our investment beliefs. The firm’s ability to implement its investment objectives depends on various considerations such as the models’ economic, analytical and mathematical underpinnings, the accurate encapsulation of those principles in a complex computational (including software code) environment, the quality of the models’ data inputs, changes in market conditions, and the successful expression of the models' views into the investment portfolio construction process. Many of these have subjective elements that present the possibility of human error. While the investment process principally relies on models, the firm’s process also incorporates the investment judgment of its portfolio managers who may exercise discretion in attempting to capture the intent of the models, particularly in changing market conditions. The firm’s success in implementing its investment objectives may depend on the ability of portfolio managers and others to interpret and implement the signals generated by the models. The firm has established certain systematic rules and processes for monitoring client portfolios to ensure that they are managed in accordance with their investment objectives, but there is no guarantee that these rules or processes will effectively manage the risks associated with its investment process under all market conditions. While the firm employs controls designed to assure that our models are sound in their development and appropriately adapted, calibrated and configured, analytical error, software development errors, and implementation errors are an inherent risk of complex analytical models and quantitative investment management processes. These errors may be extremely hard to detect, and some may go undetected for long periods of time or indefinitely. The firm’s controls, including our escalation policies, are designed to ensure that certain types of errors are subject to review once discovered. However, the effect of errors on our investment process and, where relevant, performance (which can be either positive or negative) may not be fully apparent even when discovered. When the firm discovers an investment process error in one of its models, it may in good faith and in accordance with its obligations, decide not to correct the error, to delay correction of an error, or develop other methodology to address the error, if not inconsistent with the client’s interests. Also, the firm generally will not disclose to affected clients investment process errors that are not the result of a contractual or regulatory breach, or that are non-compensable, unless it otherwise determines that information regarding the error is material to its clients.

If MSCI information appears herein, it may only be used for your internal use, it may not be reproduced or re-disseminated in any form, and it may not be used as a basis for, or a component of, any financial instruments or products or indices. None of the MSCI information is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Historical data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. The MSCI information is provided on an “as is” basis and the user of this information assumes the entire risk of any use made of this information. MSCI, each of its affiliates and each other person involved in or related to compiling, computing or creating any MSCI information (collectively, the “MSCI Parties”) expressly disclaims all warranties (including, without limitation, any warranties of originality, accuracy, completeness, timeliness, non-infringement, merchantability and fitness for a particular purpose) with respect to this information. Without limiting any of the foregoing, in no event shall any MSCI Party have any liability for any direct, indirect, special, incidental, punitive, consequential (including, without limitation, lost profits) or any other damages. (

Certain ESG data provided by and/or calculated using Trucost data. Trucost reserves all intellectual and other proprietary rights in Trucost data.


©2020 AXA Investment Managers. All rights reserved.


Please note that references to “Rosenberg Equities” herein refer solely to an expertise of AXA Investment Managers and not a specific legal entity. These materials are issued by the relevant AXA Investment Managers legal entity located in the recipient’s respective jurisdiction or region. Depending on the relevant issuing entity, the following additional disclosures may apply:

For Australian investors: AXA Investment Managers Asia (Singapore) Ltd (ARBN 115203622) is exempt from the requirement to hold an Australian Financial Services License and is regulated by the Monetary Authority of Singapore under Singaporean laws, which differ from Australian laws. AXA IM offers financial services in Australia only to residents who are “wholesale clients" within the meaning of Corporations Act 2001 (Cth).

For European investors: AXA Investment Managers UK Ltd is authorised and regulated by the Financial Conduct Authority in the United Kingdom. Registered in England and Wales No. 01431068. Registered Office: 7 Newgate Street, London EC1A 7NX. This material is intended for the use of persons meeting the MiFID client classification of Professional Clients or Eligible Counterparties and is not approved for communication to retail customers in any territory. The financial instruments used carry inherent risks which are unavoidable such as Market Risk, Credit Risk, Liquidity Risk and other risks. These risks are described in detail in our Risk Warnings document which is available upon request.

For Hong Kong investors: In Hong Kong, this document is issued by AXA Investment Managers Asia Limited (SFC License No. AAP809), which is authorized and regulated by Securities and Futures Commission. This document is to be used only by persons defined as “professional investor” under Part 1 of Schedule 1 to the Securities and Futures Ordinance (SFO) and other regulations, rules, guidelines or circulars which reference “professional investor” as defined under Part 1 of Schedule 1 to the SFO. This document must not be relied upon by retail investors. Circulation must be restricted accordingly. The authorisation of any fund by the Securities and Futures Commission in Hong Kong (“SFC”) does not imply official approval or recommendation. SFC authorization of a fund is not a recommendation or endorsement of a fund nor does it guarantee the commercial merits of a fund or its performance. It does not mean the fund is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. Where any of the Funds is not authorized by the SFC, the information contained herein in connection with such unauthorized Fund is solely for the use of professional investors in Hong Kong. Materials exempted from authorization by the SFC have not been reviewed by the SFC.

For Japanese investors: AXA Investment Managers Japan Ltd., whose registered office and principal place of business is at NBF Platinum Tower 14F 1-17-3 Shirokane, Minato-ku, Tokyo 108-0072, Japan, which is registered with the Financial Services Agency of Japan under the number KANTOZAIMUKYOKUCHO (KINSHO) 16, and is a member of Japan Securities Dealers Association, Type II Financial Instrument Firms Association, Investment Trust Association of Japan and Japan Investment Advisors Association to carry out the regulated activity of Financial Instrument Business under the Financial Instrument Exchange Law of Japan. In Japan, none of the funds mentioned in this document are registered under the Financial Instrument Exchange Law of Japan or Act on Investment Trusts and Investment Corporations. This document is purely for the information purpose for use by Qualified Institutional Investors defined by the Financial Instrument Exchange Law of Japan.

For Korean investors: In Korea, AXA Investment Managers Asia (Singapore) Ltd is a registered Cross Border Investment Advisor/Discretionary Investment Management Company under the Financial Investment Services and Capital Markets Act (the “Act”). The activities referenced under the Act are 5-2-2 Investment Advisory Business and 6-2-2 Discretionary Investment Management Business, respectively. Its financial services are available in Korea only to Professional Investors within the meaning of Article 10 of Enforcement Decree of the Financial Investment Services and Capital Markets Act. The relevant offering documents contain important information on selling restrictions and risk factors. You should read them carefully before entering into any transaction. It is your responsibility to be aware of and to observe all applicable laws and regulations of any relevant jurisdiction. To the extent that any fund is mentioned in this document, neither the fund nor AXA IM Asia is making any representation with respect to the eligibility of any recipients of this document to acquire the units/shares in the fund under the laws of Korea, including but without limitation the Foreign Exchange Transaction Act and Regulations thereunder. The units/shares have not been registered under the Financial Investment Services and Capital Markets Act of Korea, and none of the units/shares may be offered, sold or delivered, or offered or sold to any person for re-offering or resale, directly or indirectly, in Korea or to any resident of Korea except pursuant to applicable laws and regulations of Korea.

For Singapore investors: In Singapore, this document is issued by AXA Investment Managers Asia (Singapore) Ltd. (Registration No. 199001714W). This document is for use only by Institutional Investors as defined in Section 4A of the Securities and Futures Act (Cap. 289) and must not be relied upon by retail clients or investors. Circulation must be restricted accordingly.

For Swiss Investors: For Switzerland this information is intended exclusively for Qualified Investors according to Swiss law. Circulation must be restricted accordingly. The Swiss representative for the Irish-domiciled open-ended Unit Trust AXA Rosenberg Equity Alpha Trust, is First Independent Fund Services Ltd, Klausstrasse 33, CH-8008 Zurich. The Swiss paying agent is Credit Suisse, Paradeplatz 8, CH-8001 Zurich. The current prospectus, the Key Investor Information Document (the ‘KIID’) as well as the annual and semi-annual reports can be obtained free of charge from the Swiss representative. In respect of the units distributed in and from Switzerland, the place of jurisdiction is Zurich, Switzerland.

For US investors: Further information on AXA Rosenberg Investment Management LLC’s fees may be found in its Form ADV Part 2 or provided upon request. The collection of management fees produces a compounding effect on the total rate of return net of management fees. As an example, the effect of management fees on the total value of an investor’s portfolio assuming a) quarterly fee assessment, b) $1,000,000 investment, c) portfolio return of 8% a year, and d) 1.00% annual investment management fee would be $10,416 in the first year, and cumulatively $59,816 over five years and $143,430 over ten years.